Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent Implications for Rational Therapy of Restenosis
Gregory M. Lanza,Xin Yu,Patrick M. Winter,Dana R. Abendschein,Kerry K. Karukstis,Michael J. Scott,Lori Chinen,Ralph W. Fuhrhop,David E. Scherrer,Samuel A. Wickline +9 more
Reads0
Chats0
TLDR
Data suggest that targeted paramagnetic nanoparticles may provide a novel, MRI-visualizable, and quantifiable drug delivery system for the prevention of restenosis after angioplasty.Abstract:
Background—Restenosis is a serious complication of coronary angioplasty that involves the proliferation and migration of vascular smooth muscle cells (VSMCs) from the media to the intima, synthesis of extracellular matrix, and remodeling. We have previously demonstrated that tissue factor–targeted nanoparticles can penetrate and bind stretch-activated vascular smooth muscles in the media after balloon injury. In the present study, the concept of VSMC-targeted nanoparticles as a drug-delivery platform for the prevention of restenosis after angioplasty is studied. Methods and Results—Tissue factor–targeted nanoparticles containing doxorubicin or paclitaxel at 0, 0.2, or 2.0 mole% of the outer lipid layer were targeted for 30 minutes to VSMCs and significantly inhibited their proliferation in culture over the next 3 days. Targeting of the nanoparticles to VSMC surface epitopes significantly increased nanoparticle antiproliferative effectiveness, particularly for paclitaxel. In vitro dissolution studies revealed that nanoparticle drug release persisted over one week. Targeted antiproliferative results were dependent on the hydrophobic nature of the drug and noncovalent interactions with other surfactant components. Molecular imaging of nanoparticles adherent to the VSMC was demonstrated with high-resolution T1-weighted MRI at 4.7T. MRI 19 F spectroscopy of the nanoparticle core provided a quantifiable approach for noninvasive dosimetry of targeted drug payloads. Conclusions—These data suggest that targeted paramagnetic nanoparticles may provide a novel, MRI-visualizable, and quantifiable drug delivery system for the prevention of restenosis after angioplasty. (Circulation. 2002;106:2842-2847.)read more
Citations
More filters
Journal ArticleDOI
Nanotech approaches to drug delivery and imaging.
TL;DR: This review considers different nanotechnology-based drug delivery and imaging approaches, and their economic impact on pharmaceutical and biomedical industries.
Journal ArticleDOI
Nanoparticles in cellular drug delivery.
Amir H. Faraji,Peter Wipf +1 more
TL;DR: The evaluation of targeted nanoparticles in the treatment of cancers and diseases of the central nervous system, such as glioblastoma multiforme, neurovascular disorders, and neurodegenerative diseases, is discussed.
Journal ArticleDOI
Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With αvβ3-Integrin–Targeted Nanoparticles
Patrick M. Winter,Anne M. Morawski,Shelton D. Caruthers,Ralph W. Fuhrhop,Huiying Zhang,Todd A. Williams,John S. Allen,Elizabeth K. Lacy,J. David Robertson,Gregory M. Lanza,Samuel A. Wickline +10 more
TL;DR: This molecular imaging approach might provide a method for defining the burden and evolution of atherosclerosis in susceptible individuals as well as responsiveness of individual patients to antiatherosclerotic therapies.
Journal ArticleDOI
Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
Willem J. M. Mulder,Gustav J. Strijkers,Geralda A. F. van Tilborg,Arjan W. Griffioen,Klaas Nicolay +4 more
TL;DR: An overview of different lipidic nanoparticles for use in MRI is given, with the main emphasis on Gd–based contrast agents.
Journal ArticleDOI
Nanoplatforms for targeted molecular imaging in living subjects.
Weibo Cai,Xiaoyuan Chen +1 more
TL;DR: The current state-of-the-art of nanoplatforms for targeted molecular imaging in living subjects is summarized.
References
More filters
Journal ArticleDOI
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Andrea Abizaid,Fausto Feres,Ibraim Francisco Pinto,Ana C. Seixas,Rodolfo Staico,Luiz Alberto Mattos,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: In this article, the safety and efficacy of sirolimus-coated BX Velocity stents were evaluated in 30 patients with angina pectoris electively treated with two different formulations of SIROlimuscoated stents (slow release and fast release).
Journal ArticleDOI
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery
Dorothea I. Axel,W. Kunert,Christoph Göggelmann,Martin Oberhoff,Christian Herdeg,Axel Küttner,Doris H. Wild,Bernhard R. Brehm,Reimer Riessen,Gerhard Köveker,Karl R. Karsch +10 more
TL;DR: Paclitaxel inhibits haSMC proliferation and migration in a dose-dependent manner in monocultures and cocultures even in the presence of mitogens, and prevents neointima formation in rabbits after balloon angioplasty.
Journal ArticleDOI
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents One-Year Angiographic and Intravascular Ultrasound Follow-Up
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Benno J. Rensing,Andrea Abizaid,Luiz Fernando Tanajura,Ken Kozuma,Glenn Van Langenhove,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +12 more
TL;DR: This study demonstrates a sustained suppression of neointimal proliferation by sirolimus-eluting Bx VELOCITY stents 1 year after implantation.
Journal ArticleDOI
Novel MRI Contrast Agent for Molecular Imaging of Fibrin Implications for Detecting Vulnerable Plaques
Sebastian Flacke,Stefan Fischer,Michael J. Scott,Ralph Fuhrhop,John S. Allen,Mark McLean,Patrick M. Winter,Gregorio A. Sicard,Patrick J. Gaffney,Samuel A. Wickline,Gregory M. Lanza +10 more
TL;DR: Fibrin clots targeted in vitro with paramagnetic nanoparticles presented a highly detectable, homogeneous T1-weighted contrast enhancement that improved with increasing gadolinium level, suggesting that molecular imaging of fibrin-targeted param magnetic nanoparticles can provide sensitive detection and localization offibrin.
Journal ArticleDOI
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Gregory M. Lanza,Kirk D. Wallace,Michael J. Scott,William P. Cacheris,Dana R. Abendschein,Donald H. Christy,Angela M. Sharkey,James G. Miller,Patrick J. Gaffney,Samuel A. Wickline +9 more
TL;DR: These data provide the first in vivo demonstration of a site-specific ultrasonic contrast agent and have potential for improved sensitivity and specificity for noninvasive diagnosis of thrombi and other pathological diseases.